
Images are for product identification. Refer to the selected batch for packaging and availability.
Vilmist Dpi Capsules (30 Caps)
Drug Formula unavailable
YOUR PURCHASE PRICE
11 in stockInclusive of all taxes
Available batch
1 offerSign in to order for your pharmacy.
Product information
- Manufacturer
- Mankind-aspiris Div
- Category
- Other
- Composition
- Not provided
- Packaging
- 1X30CAP
- Box / case pack
- 1 / —
Description
VILMIST DPI CAPSULES (30 CAPS) by MANKIND-ASPIRIS DIV
Name:
- Brand Name: Vilmist DPI Capsules, Vilmist Inhalation Capsule
- Manufacturer: Mankind Pharma Pvt Ltd / MANKIND-ASPIRIS DIV
Composition: Vilmist DPI Capsules contain a combination of two active ingredients:
- Fluticasone Furoate: An inhaled corticosteroid, typically in strengths such as 100 mcg or 200 mcg.
- Vilanterol: A long-acting beta-agonist (LABA), typically 25 mcg. This combination helps to reduce inflammation and relax the muscles in the airways.
Uses: Vilmist DPI Capsules are prescribed for the long-term maintenance treatment of various respiratory conditions:
- Asthma: To control and prevent symptoms like wheezing and shortness of breath.
- Chronic Obstructive Pulmonary Disease (COPD): Including chronic bronchitis and emphysema, to improve airflow and reduce exacerbations.
- Allergic Rhinitis: To manage symptoms such as sneezing, runny or blocked nose, and watery eyes.
Dosage and Administration: This medication is for inhalation use only, typically administered once daily at the same time each day. It is crucial to follow the step-by-step instructions provided with the device. After inhalation, patients should rinse their mouth with water without swallowing to minimize the risk of oral fungal infections. If stored in a refrigerator, the inhaler must return to room temperature for at least an hour before use.
Side Effects: Common side effects may include:
- Headache
- Nasopharyngitis (common cold) or upper respiratory tract infection
- Fungal infection of the mouth (oral thrush)
- Back pain, abdominal pain, fever, muscle spasms
- Cough, sore throat Less common or more serious side effects should be discussed with a healthcare professional.
Precautions:
- Do not use for immediate relief of acute asthma attacks or acute COPD exacerbations; a quick-relief inhaler should be used for such episodes.
- Contraindicated in patients with known hypersensitivity to Fluticasone Furoate, Vilanterol, or milk proteins.
- Caution is advised in patients with diabetes mellitus, pulmonary tuberculosis, liver problems, severe heart problems, glaucoma, cataracts, or osteoporosis.
- Not recommended for children under 12 years of age.
- Consult a doctor if pregnant or breastfeeding.
- Avoid consuming alcohol as it may worsen side effects.
Storage: Store Vilmist DPI Capsules in their original packaging in a cool and dry place, away from moisture, heat, and direct light, typically below 30°C. Keep out of reach of children.
Frequently asked questions
Here are frequently asked questions (FAQs) about VILMIST DPI CAPSULES:
What is VILMIST DPI CAPSULES used for?
VILMIST DPI CAPSULES are primarily used for the long-term maintenance treatment of asthma and Chronic Obstructive Pulmonary Disease (COPD), including chronic bronchitis and emphysema. It helps to control symptoms like wheezing, shortness of breath, and coughing, and reduces the frequency of flare-ups. It is also used to manage symptoms of allergic rhinitis, such as sneezing, runny nose, and itchy eyes. It is important to note that this medication is not for immediate relief of sudden asthma attacks or acute episodes of COPD; a rescue inhaler should be used for such emergencies.
How does VILMIST DPI CAPSULES work?
VILMIST DPI CAPSULES contain two active ingredients: Fluticasone furoate and Vilanterol. Fluticasone furoate is an inhaled corticosteroid that reduces inflammation, swelling, and mucus production in the airways. Vilanterol is a long-acting beta-2 adrenergic agonist (LABA) that works by relaxing the smooth muscles around the airways, causing them to open up and making breathing easier. The combination provides both anti-inflammatory and bronchodilating effects for comprehensive respiratory management, with effects lasting approximately 24 hours.
What is the usual dosage of VILMIST DPI CAPSULES?
VILMIST DPI CAPSULES are typically prescribed as one capsule once daily, to be administered via a dry powder inhaler (DPI) device. It is crucial to take the medication at the same time each day for optimal results and to prevent asthma attacks. Do not exceed the prescribed dosage, as this can lead to adverse effects.
What are the possible side effects of VILMIST DPI CAPSULES?
Common side effects include headache, common cold (nasopharyngitis), upper respiratory tract infection, abdominal pain, back pain, fever, muscle spasms, cough, pneumonia, sinusitis, throat irritation, hoarse voice, mouth pain, and joint pain. To minimize the risk of a fungal infection in the mouth (oral thrush), it is recommended to rinse your mouth with water (without swallowing) after each inhalation. Serious side effects, though less common, can include allergic reactions (hives, rash, swelling of the face/throat), heart rhythm changes, increased blood pressure, low adrenal gland function, and worsening wheezing or trouble breathing immediately after use (paradoxical bronchospasm). If you experience any severe or concerning symptoms, contact your doctor immediately.
Is VILMIST DPI CAPSULES safe during pregnancy or breastfeeding?
Information regarding the safety of VILMIST DPI CAPSULES during pregnancy is not definitively available, and caution is advised. Similarly, it is unknown whether the medication passes into breast milk. Therefore, it is essential to consult your doctor if you are pregnant, planning to become pregnant, or breastfeeding to discuss the potential risks and benefits.
Can VILMIST DPI CAPSULES be taken with other medications?
VILMIST DPI CAPSULES can interact with certain medications. It should not be used with other long-acting beta agonists (LABAs) such as salmeterol, formoterol fumarate, arformoterol tartrate, or indacaterol. Caution is advised with strong CYP3A4 inhibitors (e.g., antifungal medications like ketoconazole, itraconazole, or HIV protease inhibitors like ritonavir), as they can increase the levels of fluticasone and potentially lead to more side effects. Beta-blockers may reduce the effectiveness of Vilanterol, and concurrent use should generally be avoided. It is also advisable to avoid grapefruit and grapefruit juice. Always inform your doctor about all other medications, supplements, and herbal products you are taking.
What precautions should be taken while using VILMIST DPI CAPSULES?
VILMIST DPI CAPSULES are for inhalation use only and should not be swallowed. Always use it at the same time each day as prescribed. It is not for treating acute asthma attacks; a separate rescue inhaler should be used for sudden breathing difficulties. Rinse your mouth with water without swallowing after each use to prevent oral fungal infections. Do not open and close the inhaler unnecessarily, as this can lead to a lost dose. Avoid breathing out into the mouthpiece. Children under 12 years of age should not use this medication. Inform your doctor if you have a history of diabetes, heart problems, liver problems, tuberculosis, or conditions like glaucoma, cataracts, or osteoporosis, as these may require special monitoring or adjustments.
What happens if a dose of VILMIST DPI CAPSULES is missed?
If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose or an extra dose to make up for a missed one, and never take more than one inhalation per day.
How should VILMIST DPI CAPSULES be stored?
Store VILMIST DPI CAPSULES in its original packaging at room temperature, typically below 30°C (or 20-25°C), away from moisture, heat, and direct sunlight. Keep the medication out of the sight and reach of children. Once opened, the inhaler should be discarded after 6 weeks or when the dose counter reads zero, whichever comes first (some sources indicate 6 months after opening the foil tray, consult package insert for specific instructions).